LABELS, SIGNALING & DETECTION
	Cambridge Healthtech Institute , Washington, DC June 12-13, 2000
	Extending the limits of assay sensitivity and accuracy, while also meeting the demand for greater throughput and/or lower cost, requires tightening engineering specifications and acquiring innovative techniques and systems. The development of new probes and labels, homogeneous assay designs, and approaches that allow for the direct detection of compounds or specific binding events is having an impact in basic research, diagnostic, and drug development segments. Novel fluorescent and luminescent technology is also critical for the implementation of greater speed and automation. Advances in miniaturization, including microarrays, are having a significant impact in meeting these goals. These advances are being applied to the detection, quantification and localization of gene sequences, proteins, infectious organisms, contaminants, and a variety of other targets.
	Organized by:	Cambridge Healthtech Institute
	Deadline for Abstracts:	May 5, 2000
	Registration:
	Email for Requests and Registration:	jlaakso@healthtech.com
	Posted by: Jennifer Laakso   Host: 140.239.39.137 date: January 20, 2000 15:27:05 Generated by meetings and positions 2.0 by Kai Garlipp Logo and Logo Images by Art for BioMed / Syrinx GmbH - Frankfurt / Germany. 4.1 (c) 1995-99 HUM-MOLGEN. All rights reserved. Liability and Copyright.